| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 30,404 | 40,778 | 38,459 | 13,327 | | Cost of Revenue | 11,037 | 12,074 | 12,651 | 14,232 | | | Gross Profit |
-
| 28,704 | 25,808 | (905) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,213 | 17,262 | 16,339 | (8,844) | | Non Recurring |
-
|
-
|
-
| 10,857 | | Others | 3,281 | 13,433 | 9,792 | 2,804 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (1,991) | (323) | (5,722) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 873 | (1,991) | (323) | (5,722) | | Interest Expense | 2,313 | 2,630 | 3,048 | 3,584 | | Income Before Tax | (1,440) | (4,621) | (3,371) | (9,306) | | Income Tax Expense | (573) | (1,707) | (1,692) | (3,859) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (867) | (2,914) | (1,679) | (5,447) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 4,949 | 1,950 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (867) | (2,914) | 3,270 | (3,497) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($867) | ($2,914) | $3,270 | ($3,497) |
|
0.03% Nasdaq 0.00%
Income Statement
